SPEZIFISCHE BINDUNGSMOLEKÜLE

European patent · EP3688030 · In force

Register entry

Publication number
EP3688030
Application number
EP18780089
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Sep 27, 2018
Published
Aug 5, 2020
Granted
Dec 11, 2024
Protection ends at the latest
Sep 26, 2038
Next annual fee due
Sep 30, 2027
IPC classes
C07K 16/18 (2006.01)
C07K 16/24 (2006.01)
C07K 16/28 (2006.01)
A61K 39/395 (2006.01)
A61P 37/06 (2006.01)
C07K 16/46 (2006.01)
Priority
US 201762563948 P 27.09.2017
US 201862667126 P 04.05.2018
PCT application
PCT/EP2018/076333 27.09.2018
PCT publication
WO2019/063726 04.04.2019
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Oct 1, 2026

    Next annual fee due on

    Next annual fee due on
    30.09.2026 → 30.09.2027

    Published in Swissreg on 01.10.2026

  2. Oct 22, 2025

    Change

    Published in Swissreg on 22.10.2025

  3. Oct 1, 2025

    Next annual fee due on

    Next annual fee due on
    30.09.2025 → 30.09.2026

    Published in Swissreg on 01.10.2025

  4. Dec 11, 2024

    Granted

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 11.12.2024

Parties

Holder

Elasmogen Ltd

Liberty Building Foresterhill Health Research Complex Foresterhill Road, Aberdeen, Aberdeenshire AB25 2ZP, GB

Inventor

UBAH, Obinna

Aberdeen Aberdeenshire AB25 2ZP, GB

BARELLE, Caroline

Aberdeen Aberdeenshire AB25 2ZP, GB

PORTER, Andrew

Aberdeen Aberdeenshire AB25 2ZP, GB

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.